Becky Fahrenbruch graduated from University of Nebraska Medical Center with her PharmD. She completed a Pharmacy Practice Residency at Southwest Washington Medical Center in Vancouver, WA and Oncology Specialty Residency at MD Anderson Cancer Center in Houston, TX. She became a Board Certified Oncology Pharmacist (BCOP) in 2002.
Becky is currently a Medical Science Liaison in Myeloid Hematology for Bristol-Myers Squibb, formerly Celgene. She previously worked as the Oncology Pharmacy Manager at University of Minnesota Health Oncology Infusion Pharmacy in Maple Grove, Minnesota and as the Residency Program Director for the PGY2 Oncology Pharmacy Residency program for 12 years. Other experience includes working as a Clinical Assistant Professor at the University of Minnesota, COP and as a mentor for the Leadership Networking Partners program.
She is involved in leadership roles and committee work, and she is a speaker for many local and national organizations, including HOPA, ACCP, ACCC, and APhA. For 18 years, she has coordinated an Oncology Journal Club for Pharmacist and is a current board member for Upper Midwest Oncology Education Network (UMOEN) and Kappa Psi Pharmaceutical Foundation.